| Stage | LLY | % of rev | ZVRA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $24.4B | 100.00% | $38M | 100.00% | LLY ×646.18 |
| Gross profit | $20.5B | 83.88% | $36M | 95.25% | ZVRA +11.4pp |
| Operating income | $8.6B | 35.28% | $12M | 30.67% | LLY +4.6pp |
| Pre-tax income | $8.4B | 34.46% | $20M | 52.22% | ZVRA +17.8pp |
| Net income | $6.5B | 26.44% | $19M | 50.87% | ZVRA +24.4pp |
| Stage | LLY | ZVRA | Gap · A − B |
|---|---|---|---|
| Revenue | $24.4B100.00% | $38M100.00% | LLY ×646.18 |
| Gross profit | 83.88%$20.5B | 95.25%$36M | ZVRA +11.4pp |
| Operating income | 35.28%$8.6B | 30.67%$12M | LLY +4.6pp |
| Pre-tax income | 34.46%$8.4B | 52.22%$20M | ZVRA +17.8pp |
| Net income |
| 26.44%$6.5B |
| 50.87%$19M |
| ZVRA +24.4pp |
No shared counterparties.